GlassScriptPhysician profile
Naren Patel
NPI 1609288638
$9,692.49
in general payments reported to CMS, 2019-2025
9 companies · $65.72 in 2025
The $65.72 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2020: $812 · 2021: $172 · 2022: $4,549 · 2023: $3,914 · 2024: $14.81 · 2025: $65.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,675 · Food and Beverage: $320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,675.00 |
| Food and Beverage | $319.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $8,320.19 | 2021-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Polarityte, INC. | $740.00 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $199.88 | 2022 | |
| Smith+Nephew, INC. | $171.01 | 2019-2021 | |
| Treace Medical Concepts, INC. | $134.70 | 2023-2024 | |
| Amdt Holdings, INC. | $71.71 | 2020 | |
| Merck Sharp & Dohme LLC | $28.40 | 2019 | |
| Stryker Corporation | $15.40 | 2023 | Prostep |
| Accufix Surgical INC. | $11.20 | 2025 | Accu-Joint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naren Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.